Potential strategies for the management of drug resistant tuberculosis.

Clicks: 239
ID: 100753
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #39 of 113 articles by views in Journal of global antimicrobial resistance

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
In the current scenario, the emergence of drug resistance in Mycobacterium tuberculosis is the consequence of the failure of conventional diagnostics and treatment approach. To combats this global emergence of drug resistance, alternative approaches such as pathogen centric (use of repurposed drugs, novel analogs of existing anti-TB drugs and novel compounds a different mechanism of action), host-centric (immunomodulatory agents, therapeutic vaccines, immune and cellular therapies) and nano-based drugs/vaccines delivery approaches should be used in single or in combination. Diverse types of nano-carriers have gauged as auspicious diagnostics and drug delivery systems. In this focused review, we have suggested a long-term solution for combating the antimicrobial resistance and also an attractive means to increase patient's compliance and reduce treatment duration.
Reference Key
sharma2020potentialjournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sharma, Divakar;Sharma, Sandeep;Sharma, Juhi;
Journal Journal of global antimicrobial resistance
Year 2020
DOI
S2213-7165(20)30058-8
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.